Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Nov 20, 2014

Cepheid to Webcast Upcoming Financial Presentations
Nov 13, 2014

Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic

With Funding from the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, Cepheid Expects to Deliver Prototype in as Little as Eight Weeks
Oct 28, 2014

Cepheid, FIND & Rutgers Announce Collaboration for Next-Generation Innovations to Game-changing Xpert MTB/RIF Test
Oct 16, 2014

Cepheid Reports 2014 Third Quarter Results

Commercial Clinical Grows 23% Driven by 25% Growth in Xpert Tests
Oct 1, 2014

Cepheid Extends Reach Of Direct US Commercial Operations

Acquires Customer Relationships from Former Distribution Partner
Oct 1, 2014

Cepheid Schedules 2014 Third Quarter Results Announcement And Webcast
Sep 4, 2014

Cepheid Recognized as Innovation Leader
Sep 3, 2014

Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections

First molecular test indicated for samples from both males and females
Sep 2, 2014

Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection

Redundant targets extend coverage to provide detection of seasonal and emerging novel viruses
Jul 31, 2014

Cepheid to Webcast Upcoming Financial Presentations

Show per page

Back to Top